OVERLAND PARK, Kan.; January 14, 2025 (Business Wire) – Dr. Vince Clinical Research (DVCR), a contract research organization (CRO), announces the expansion of its research campus by constructing a new 5,000-square-foot administration building in Overland Park, Kansas. This project continues its breakthrough expansion for the company as it enhances its clinical research capabilities and services. The organization currently has well over 175 employees across the United States, Canada, Europe and the United Kingdom.
The new administration building will support finance, human resources and volunteer recruitment departments, enabling operational efficiencies and enhancing service offerings to better serve the needs of its clients. Strategically located on the current 75,000-square-foot research campus, the new building will mirror the existing headquarters, providing architectural and design continuity.
“We are proud to commence construction on yet another building on our research campus,” stated Dr. Brad Vince, CEO and Chief Medical Officer at Dr. Vince Clinical Research.
“Our original goal was to create a world-class contract research organization. The new administration building will help us achieve this goal by further facilitating our day-to-day operations and fostering collaboration and innovation amongst our team,” added Dr. Vince.
The expansion project received unanimous approval from the Overland Park Planning Commission in March 2024, highlighting the support and enthusiasm for Dr. Vince Clinical Research’s growth within the community and the biopharmaceutical industry. Construction has just commenced with completion expected within one year.
About Dr. Vince Clinical Research
Dr. Vince Clinical Research (DVCR) is a full-service contract research organization (CRO) specializing in early phase trials in both healthy normal volunteers and patient populations across a wide range of trial designs and therapeutic areas such as neuroscience, substance abuse, pain, cardiometabolic disorders, infectious diseases and many others. CRO services include project management, data management, biostatistics, statistical programming, PK/PD analysis, medical writing, monitoring, site feasibility and management for multi-site trials.
Additionally, DVCR operates one of the most innovative and technologically advanced clinical pharmacology units in the world with over 90 beds for overnight confinement, a clinical laboratory, a surgical suite, a cGMP compliant pharmacy, as well as luxurious amenities to support diverse study participant recruitment and retention. By leveraging technology and one of the country’s most experienced leadership teams in early clinical development, DVCR provides Smarter Faster Data® to their biopharmaceutical clients.
For more information, go to sponsors.drvince.com. Connect with Dr. Vince Clinical Research on LinkedIn and YouTube.
DVCR Contact
Salvador Solis
Director, Business Development
(913) 333-3000
Dr. Vince Clinical Research
info@drvince.com